Поиск | SPORTIVO Network

sonalisonkusare добавлена новая статья Другое
2026-03-20 12:42:22

Clinical Oncology Next Generation Sequencing Market In-Depth Research Report with Industry Forecast
"Global Executive Summary Clinical Oncology Next Generation Sequencing Market Market: Size, Share, and Forecast Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029. The complete...

0 Комментарии 0 Поделились 675 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
harshasharma добавлена новая статья Другое
2026-03-10 08:44:52

Immuno Oncology Assays Market: Insights and Competitive Analysis
Executive Summary Immuno Oncology Assays Market Size and Share Across Top Segments CAGR Value The global immuno oncology assays market size was valued at USD 6.80 billion in 2025 and is expected to reach USD 16.45 billion by 2033, at a CAGR of 11.68% during the forecast period To better structure this Immuno Oncology Assays report, a nice blend of...

0 Комментарии 0 Поделились 333 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
dbmr456 добавлена новая статья Другое
2026-03-17 08:54:30

Taxane-Based Oncology Drug Class Market Overview: Key Drivers and Challenges 2025 –2032
Executive Summary Taxane-Based Oncology Drug Class Market Market: Growth Trends and Share Breakdown CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period This global Taxane-Based Oncology Drug Class Market...

0 Комментарии 0 Поделились 504 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
rishika_2003 добавлена новая статья Health
2026-03-13 10:16:02

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
PrathameshGavade добавлена новая статья Главная
2025-10-08 07:02:25

Advances in Molecular Oncology Diagnostics Market : Understanding the Market and Its Potential
The Global Molecular Oncology Diagnostics Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the Molecular Oncology Diagnostics Market in each key region of the world. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth...

0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
VIshalkumar009 добавлена новая статья Главная
2026-03-11 10:10:55

Antibody Drug Conjugates (ADCs) Market Insights 2026: Precision Oncology Transformation
The landscape of cancer treatment is undergoing a seismic shift. Gone are the days when "scorched earth" chemotherapy was the only viable path for late-stage patients. Today, we are living in the era of the "magic bullet" , a concept first envisioned by Paul Ehrlich over a century ago now realized through the Antibody Drug Conjugates (ADCs) Market. By combining the laser-like precision of...

0 Комментарии 0 Поделились 679 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
priyanka добавлена новая статья Другое
2025-11-27 07:53:48

Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine Applications
The global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...

0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
priyanka добавлена новая статья Другое
2025-11-27 07:54:44

Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine Applications
The global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...

0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
priyanka добавлена новая статья Другое
2025-11-27 07:54:54

Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine Applications
The global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...

1

0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
rishika_2003 добавлена новая статья Health
2026-03-13 07:55:34

Global Altretamine Market to Reach USD 210 Million by 2034, Driven by Rising Ovarian Cancer Cases and Advancements in Oncology Therapies
According to new market intelligence from Intel Market Research, the global Altretamine market was valued at USD 120 million in 2024, with projections indicating steady growth to USD 210 million by 2034 at a CAGR of 5.8% during the forecast period (2026-2034). This expansion reflects increasing adoption in oncology treatment protocols, particularly for platinum-resistant ovarian cancer cases,...

0 Комментарии 0 Поделились 315 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
rishika_2003 добавлена новая статья Health
2026-03-16 06:30:43

Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology Adoption
According to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...

0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
priyanka добавлена новая статья Другое
2025-11-28 05:54:35

Global Cancer Drugs Market Set for Exponential Growth, Targeting USD 1.81 Billion by 2032 as Immunotherapies Reshape Oncology Landscape
Market Projected to Accelerate at 4.71% CAGR Driven by Precision Medicine Adoption and the Rise of Novel Cell and Gene Therapies The global Cancer Drugs Market, highlighting a profound shift toward curative and highly targeted therapeutic modalities. The market, valued at a substantial USD 1.19 Billion in 2023, is projected to reach USD 1.81 Billion by 2032, recording a robust Compound Annual...

0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
stephengrey169 добавлена новая статья Другое
2026-03-24 13:22:33

Accelerating Cancer Research: Patient Derived Xenograft Model Market Opportunities, Size & Forecast 2031
The Patient‑Derived Xenograft Model Market is becoming a critical pillar in oncology research and drug discovery as global demand for predictive preclinical platforms continues to rise. According to the latest market intelligence, the Patient‑Derived Xenograft Model Market was valued at US$ 468.75 million in 2024 and is projected to reach US$ 1,119.36 million by 2031, reflecting a compound...

0 Комментарии 0 Поделились 845 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Kumud добавлена новая статья Health
2026-03-31 12:16:07

All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%
According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...

0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
naznins407 добавлена новая статья Health
2026-02-26 08:22:57

Anti-Radiation Drugs Market Size, Share, and Strategic Outlook
Advancements in biotechnology are enabling the development of more targeted radioprotective treatments. These innovations improve cellular protection while minimizing adverse effects. The evolving therapeutic landscape supports sustained market progress. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...

0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Kumud добавлена новая статья Health
2026-03-27 12:55:09

Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%
According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...

0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Kumud добавлена новая статья Health
2026-04-07 12:36:34

Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%
According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...

0 Комментарии 0 Поделились 711 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Kumud добавлена новая статья Health
2026-04-08 12:58:09

Bone Metastasis Therapeutics Market Growth & CAGR 8.3% Forecast
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...

0 Комментарии 0 Поделились 664 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Kumud добавлена новая статья Health
2026-04-08 13:01:29

Bone Metastasis Therapeutics Market Growth & CAGR 8.3% Forecast
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...

0 Комментарии 0 Поделились 625 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
NikitaG добавлена новая статья Другое
2025-12-10 07:24:21

Cancer/Tumor Profiling Market Size Projected to Reach USD 23.4 Billion by 2032
“According to a new report published by Introspective Market Research, Cancer/Tumor Profiling Market by Technology, Cancer Type, and Application, The Global Cancer/Tumor Profiling Market Size Was Valued at USD 11.08 Billion in 2024 and is Projected to Reach USD 23.4 Billion by 2032, Growing at a CAGR of 9.8%.” Cancer/Tumor Profiling refers to the comprehensive molecular examination...

0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
rishika_2003 добавлена новая статья Health
2026-03-13 09:33:39

Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma Therapies
According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...

1

0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!

Расширенные страницы